Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
Chang AR, Evans M, Yule C, Bohn L, Young A, Lewis M, Graboski E, Gerdy B, Ehmann W, Brady J, Lawrence L, Antunes N, Green J, Snyder S, Kirchner HL, Grams M, Perkins R.
Chang AR, et al.
BMC Nephrol. 2016 Nov 8;17(1):168. doi: 10.1186/s12882-016-0383-7.
BMC Nephrol. 2016.
PMID: 27825313
Free PMC article.
Clinical Trial.